UK: Haemophilia: The Impact Of A Single Gene Disorder On World History

Last Updated: 20 April 2016
Article by Deloitte LLP

Most Read Contributor in UK, August 2017

Earlier this week I was discussing our up and coming Healthcare and Life Sciences Essentials course with a new joiner Pavithra Rallapalli, known as Pavi, who recently completed her Post doctoral fellowship at University College London. Her experience was facinating and, not one to miss a chance, I asked Pavi whether she might be interested in writing a Centre blog, and if so what would she want to write about.

She replied almost immediately asking me if I had heard/read about the haemophilia B gene that Queen Victoria carried and how she, through the marriages of her children, passed the disorder to many other royal families. The genetic mutation played a role in the Russian revolutions and the fall of a number of other royal households. While I was aware of the basic facts, and had seen a number of films that alluded to the problem, I admitted that my knowledge was limited and agreed that I thought our readers would enjoy understanding more about this. This week's blog, therefore, presents Pavi's narration of Haemophilia and its role in the downfall of royal families across Europe.

Many of you may well have read or heard about Haemophilia, and the fact that it is often referred to as "the royal disease". But before I discuss the devastation it caused in royal households during the the 19th and 20th Century I thought I should explain a little about the nature and cause of Haemophilia.

Haemophilia is a rare bleeding disorder in which the blood fails to clot normally. Think of your body as controlled by a large network, with lots of small and interconnected branches/departments, headed by a single gene or a group of genes, with some lateral sense of hierarchy to maintain order. One such small, yet significant network is your coagulation cascade – A group of genes that operate together, to form clots, to prevent the loss of blood at any site of injury. Much like a 24/7 stand-by support team. When the body's protective layer is breeched by a cut, a blow, a tear, the team jumps immediately into action to deliver a fix (a blood clot).

The coagulation cascade has 14 core genes and several other extended and supporting genes. With regard to Haemophilia, there are two core genes - Factor 8 (F8) and Factor 9 (F9), both from the X chromosome. Any mutation in these two genes stops the cascading effect and stops the blood from clotting, this condition is called Haemophilia A (in the case of a dysfunctional F8 gene), and Haemophilia B (in the case of a dysfunctional F9 gene). Haemophilia A and B are hereditary haemorrhagic disorders characterised by deficiency or dysfunction of coagulation genes. Haemophilia being an X-chromosome originator, affects mostly men. Women are usually only the carriers of the disease (the gene with the mutation that is) and pass on the mutation reproductively. This is the case with all the X-chromosome genes; women have two X chromosomes (XX) and men have only one (XY). So even if the woman has a mutation in one of her X chromosome genes, she most likely has another normal copy of the same gene from her other X chromosome. Patient statistics suggest that 1 in 5,000 are affected by Haemophilia A while 1 in 50,000 are affected my Haemophilia B. Hopefully, this brief introduction provides enough background to gain a sense of the principle of Haemophilia. But if you would like to know more, please use other sources available online (For example, the World Federation of Hemophilia).

My own interest in Haemophilia and the reason for choosing it as the subject of this blog is that this disorder is a powerful model of how a healthcare problem can have a wide-ranging impact on other areas and on people's lives and events far removed from the disease itself. The improvement in the quality of life of the patients and the science behind this disorder and subsequently its cure, go hand in hand with technological, clinical and biomedical advancements: From increased understanding of the disease, to the discovery & later the production of recombinant proteins (which is widely administered as a drug to manage the bleeding), the use of the internet in bringing together patients and the support community, and advancements in bioinformatics, molecular modelling and gene therapy. Today there is hope and a potential cure for the disorder which was unimaginable 100 years ago. Haemophilia is a rare disorder, and the patient information, research data and any other relevant information, although complex to interpret, is relatively limited in scale due to the small population of people affected. But if you were to project this case study on to other more prevalent diseases like diabetes, cystic fibrosis or even cancer, you can get a sense of why such insights are important and the need to manage and study them strategically.

Getting to the crux of this story, Queen Victoria and her reign in 19th century England (1819 -1901). The then queen carried a Factor 9 gene mutation, having married Albert (Prince of Saxe-Coburg-Gotha) she went on to have 9 children (4 boys and 5 girls) and unwittingly passed on the haemophilia B gene to 3 of their children. Prince Leopold had Haemophilia B and died of a haemorrhage after a fall when he was 30, while Princess Alice and Princess Beatrice were carriers of this mutation. The evidence that the genetic variant passed down by Queen Victoria was a F9 mutation causing haemophilia B was not discovered until 2009, when a group of scientist decided to genotype the remains of the Romanov family.1

Through the marriage of Princess Alice and Princess Beatrice, this mutation was carried on to the German royal family, and subsequently, through the marriage of their own "carrier" daughters to the Russian and Spanish royal families in the 19th and 20th centuries. Alice's son Friedrich died of severe bleeding due to haemophilia after sustaining an injury. Alice's daughter Alix, who married Nicholas II of Russia, passed on the carrier mutant F9 gene to the Russian royal family. Had Alix, accepted the offer of marriage from Prince Albert in 1890, or his brother Prince George, as intended by Queen Victoria, haemophilia would have been re-introduced into the reigning branch of the British royal family. But Alix married Tsar Nikolas II instead and carried the disease into the Russian Romanov imperial family. She had four daughters before giving birth to the long-awaited son, Alexis, heir to the Russian throne. Once the parents realised their only son had haemophilia, they were distressed and tried everything to find a cure distracting them from the growing state of unrest in the country. Finally, they turn to the "spiritualist" Rasputin, who claimed to be able to relieve their son of his pain. Meanwhile, the deterioration in public affairs culminated in the Russian revolution, and the assassination of the Russian royal family.

The Russian royal family's entanglement with Rasputin, and their deaths during the Bolshevik Revolution have been well chronicled. Less well known is the marriage of Princess Beatrice's daughter, Victoria, to Alfonso XIII of Spain. Beatrice passed on her mutation to the Spanish royal family. Haemophilia was subsequently carried through various royal family members for three generations, before disappearing. The above narration covers hundreds of pages of history so hopefully the image below should help illustrate the trajectory of the royal health hazard, otherwise known as haemophilia. 2


In Queen Victoria's time there was no cure for haemophilia, indeed, like most genetic disorders prior to the 1960s when effective treatment became available, average life expectancy for haemophiliacs was only 11 years. By the 1980's the life span of the average haemophiliac receiving appropriate anti-coagulant treatment, was 50–60 years. Today with newer more targeted gene therapy persons with haemophilia typically have a near normal quality of life with an average lifespan approximately 10 years shorter than an unaffected male. Today, when we talk about drug development, we do not only mean small drug molecules, but therapeutics also include drug, gene or cell therapy. My reason for sharing this story is to illustrate how our understanding and treatment of diseases has developed and more importantly to remind you that behind every treatment or discovery there is a history, and the importance of sometimes thinking beyond, looking deeper and connecting the dots.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.